122 related articles for article (PubMed ID: 1847215)
1. Human rhinovirus 14 complexed with antiviral compound R 61837.
Chapman MS; Minor I; Rossmann MG; Diana GD; Andries K
J Mol Biol; 1991 Feb; 217(3):455-63. PubMed ID: 1847215
[TBL] [Abstract][Full Text] [Related]
2. Human rhinovirus 14 complexed with fragments of active antiviral compounds.
Bibler-Muckelbauer JK; Kremer MJ; Rossmann MG; Diana GD; Dutko FJ; Pevear DC; McKinlay MA
Virology; 1994 Jul; 202(1):360-9. PubMed ID: 8009848
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and activity of piperazine-containing antirhinoviral agents and crystal structure of SDZ 880-061 bound to human rhinovirus 14.
Oren DA; Zhang A; Nesvadba H; Rosenwirth B; Arnold E
J Mol Biol; 1996 May; 259(1):120-34. PubMed ID: 8648640
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the anti-rhinoviral drug binding pocket in HRV14 and HRV1A.
Kim KH; Willingmann P; Gong ZX; Kremer MJ; Chapman MS; Minor I; Oliveira MA; Rossmann MG; Andries K; Diana GD
J Mol Biol; 1993 Mar; 230(1):206-27. PubMed ID: 8383771
[TBL] [Abstract][Full Text] [Related]
5. Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses.
Badger J; Minor I; Oliveira MA; Smith TJ; Rossmann MG
Proteins; 1989; 6(1):1-19. PubMed ID: 2558377
[TBL] [Abstract][Full Text] [Related]
6. Structure determination of antiviral compound SCH 38057 complexed with human rhinovirus 14.
Zhang A; Nanni RG; Li T; Arnold GF; Oren DA; Jacobo-Molina A; Williams RL; Kamer G; Rubenstein DA; Li Y
J Mol Biol; 1993 Apr; 230(3):857-67. PubMed ID: 8386772
[TBL] [Abstract][Full Text] [Related]
7. Analysis of three structurally related antiviral compounds in complex with human rhinovirus 16.
Hadfield AT; Diana GD; Rossmann MG
Proc Natl Acad Sci U S A; 1999 Dec; 96(26):14730-5. PubMed ID: 10611281
[TBL] [Abstract][Full Text] [Related]
8. Structural analysis of a series of antiviral agents complexed with human rhinovirus 14.
Badger J; Minor I; Kremer MJ; Oliveira MA; Smith TJ; Griffith JP; Guerin DM; Krishnaswamy S; Luo M; Rossmann MG
Proc Natl Acad Sci U S A; 1988 May; 85(10):3304-8. PubMed ID: 2835768
[TBL] [Abstract][Full Text] [Related]
9. Structural studies on human rhinovirus 14 drug-resistant compensation mutants.
Hadfield AT; Oliveira MA; Kim KH; Minor I; Kremer MJ; Heinz BA; Shepard D; Pevear DC; Rueckert RR; Rossmann MG
J Mol Biol; 1995 Oct; 253(1):61-73. PubMed ID: 7473717
[TBL] [Abstract][Full Text] [Related]
10. Human rhinovirus 3 at 3.0 A resolution.
Zhao R; Pevear DC; Kremer MJ; Giranda VL; Kofron JA; Kuhn RJ; Rossmann MG
Structure; 1996 Oct; 4(10):1205-20. PubMed ID: 8939746
[TBL] [Abstract][Full Text] [Related]
11. Dissociation of an antiviral compound from the internal pocket of human rhinovirus 14 capsid.
Li Y; Zhou Z; Post CB
Proc Natl Acad Sci U S A; 2005 May; 102(21):7529-34. PubMed ID: 15899980
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the structure of a common cold virus, human rhinovirus 14, refined at a resolution of 3.0 A.
Arnold E; Rossmann MG
J Mol Biol; 1990 Feb; 211(4):763-801. PubMed ID: 2156077
[TBL] [Abstract][Full Text] [Related]
13. Conformational change in the floor of the human rhinovirus canyon blocks adsorption to HeLa cell receptors.
Pevear DC; Fancher MJ; Felock PJ; Rossmann MG; Miller MS; Diana G; Treasurywala AM; McKinlay MA; Dutko FJ
J Virol; 1989 May; 63(5):2002-7. PubMed ID: 2539499
[TBL] [Abstract][Full Text] [Related]
14. The structure of antiviral agents that inhibit uncoating when complexed with viral capsids.
Rossmann MG
Antiviral Res; 1989 Feb; 11(1):3-13. PubMed ID: 2540708
[TBL] [Abstract][Full Text] [Related]
15. Molecular dynamics simulations of human rhinovirus and an antiviral compound.
Speelman B; Brooks BR; Post CB
Biophys J; 2001 Jan; 80(1):121-9. PubMed ID: 11159387
[TBL] [Abstract][Full Text] [Related]
16. Cryo-EM structure of pleconaril-resistant rhinovirus-B5 complexed to the antiviral OBR-5-340 reveals unexpected binding site.
Wald J; Pasin M; Richter M; Walther C; Mathai N; Kirchmair J; Makarov VA; Goessweiner-Mohr N; Marlovits TC; Zanella I; Real-Hohn A; Verdaguer N; Blaas D; Schmidtke M
Proc Natl Acad Sci U S A; 2019 Sep; 116(38):19109-19115. PubMed ID: 31462495
[TBL] [Abstract][Full Text] [Related]
17. Structural studies of two rhinovirus serotypes complexed with fragments of their cellular receptor.
Kolatkar PR; Bella J; Olson NH; Bator CM; Baker TS; Rossmann MG
EMBO J; 1999 Nov; 18(22):6249-59. PubMed ID: 10562537
[TBL] [Abstract][Full Text] [Related]
18. The structure of human rhinovirus 16.
Oliveira MA; Zhao R; Lee WM; Kremer MJ; Minor I; Rueckert RR; Diana GD; Pevear DC; Dutko FJ; McKinlay MA
Structure; 1993 Sep; 1(1):51-68. PubMed ID: 7915182
[TBL] [Abstract][Full Text] [Related]
19. WIN 52035-2 inhibits both attachment and eclipse of human rhinovirus 14.
Shepard DA; Heinz BA; Rueckert RR
J Virol; 1993 Apr; 67(4):2245-54. PubMed ID: 8383239
[TBL] [Abstract][Full Text] [Related]
20. Motion of an antiviral compound in a rhinovirus capsid under rotational symmetry boundary conditions.
Yoneda S; Yoneda T; Kurihara Y; Umeyama H
J Mol Graph Model; 2002 Aug; 21(1):19-27. PubMed ID: 12413027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
